N,N'-dithenylurea derivatives used in the form of kinase inhibitors

Details for Australian Patent Application No. 2005293821 (hide)

Owner Merck Patent GmbH

Inventors Staehle, Wolfgang; Rautenberg, Wilfried; Hoelzemann, Guenter

Agent Davies Collison Cave

Pub. Number AU-B-2005293821

PCT Pub. Number WO2006/040039

Priority 04024367.7 13.10.04 EP

Filing date 4 October 2005

Wipo publication date 20 April 2006

Acceptance publication date 12 May 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/040039 Priority application(s): WO2006/040039

12 May 2011 Application Accepted

  Published as AU-B-2005293821

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293830-Acidic and buffered skin-care compositions comprising nicotinamid and an absorbing agent

2005293820-Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders